Cell of the FAHF-2 treated mice mesenteric lymph nodes (MLNs) secreted less IL-4 and IL-5 and more IFN-, which coincided with more IFN--producing CD8 + T cells [34] confirming a long-term shift of Th2 and Th1 milieu in response to FAHF-2 treatment in vivo
[60] [61] About 2040% of healthy people between 60 and 78 years old experience discernable decrements in cognitive performance in several domains including working, spatial, and episodic memory, and processing speed
Chadebech P, Michel M, Janvier D, Yamada K, Copie-Bergman C, Bodivit G, et al
Compound AOD-9604 Class Synthetic hGH C-terminal fragment (16 aa) FDA Status Not FDA-approved Evidence Strength Phase 2b primary endpoint missed
Human studies, while smaller in scale, support both efficacy and safety over extended periods